-transparent.png){kind=logo}
The workers engaged in the processing of the UP-671, UP-671D, UP-677, UP-680 and UP-682 epoxide resins are influenced by both initial and intermediate industrial products, as well as the resins' volatile components in MAC threshold concentrations. The workers engaged in major professions displayed upper respiratory allergic diseases, contact and allergic dermatitis, sensibilization to epichlorhydrine, staphylococci and kidney allergen. Euthyroid goiter was diagnosed in most workers, along with thriiodothyronine decrease in blood serum and a higher rate of chromosomal aberrations in lymphocytes. The experimental studies performed revealed moderate-degree toxicity in the resins, their cumulation properties, as well as allergenic, irritating, mutagenic and embryotoxic characteristics. Basing on the results of the study, the USSR Health Ministry adopted the working zone air MAC for the resins at the level of 0.5 mg/m3, vapours, 2nd degree of hazardousness.
Iu N Talakin, and
L V Chernykh, and
V V Zholos, and
N M Otroshchenko, and
M V Savchenko, and
I A Nekrasova, and
L A Ivanova, and
V I Krishtopa
February 1980,
Gigiena truda i professional'nye zabolevaniia,
Iu N Talakin, and
L V Chernykh, and
V V Zholos, and
N M Otroshchenko, and
M V Savchenko, and
I A Nekrasova, and
L A Ivanova, and
V I Krishtopa
January 1977,
Gigiena truda i professional'nye zabolevaniia,
Iu N Talakin, and
L V Chernykh, and
V V Zholos, and
N M Otroshchenko, and
M V Savchenko, and
I A Nekrasova, and
L A Ivanova, and
V I Krishtopa
January 1965,
Occupational health review,
Iu N Talakin, and
L V Chernykh, and
V V Zholos, and
N M Otroshchenko, and
M V Savchenko, and
I A Nekrasova, and
L A Ivanova, and
V I Krishtopa
December 1961,
Gigiena truda i professional'nye zabolevaniia,
Iu N Talakin, and
L V Chernykh, and
V V Zholos, and
N M Otroshchenko, and
M V Savchenko, and
I A Nekrasova, and
L A Ivanova, and
V I Krishtopa
October 1978,
Gigiena truda i professional'nye zabolevaniia,
Iu N Talakin, and
L V Chernykh, and
V V Zholos, and
N M Otroshchenko, and
M V Savchenko, and
I A Nekrasova, and
L A Ivanova, and
V I Krishtopa
April 2019,
Molecules (Basel, Switzerland),
Iu N Talakin, and
L V Chernykh, and
V V Zholos, and
N M Otroshchenko, and
M V Savchenko, and
I A Nekrasova, and
L A Ivanova, and
V I Krishtopa
July 1983,
Gigiena truda i professional'nye zabolevaniia,
Iu N Talakin, and
L V Chernykh, and
V V Zholos, and
N M Otroshchenko, and
M V Savchenko, and
I A Nekrasova, and
L A Ivanova, and
V I Krishtopa
November 2008,
Contact dermatitis,
Iu N Talakin, and
L V Chernykh, and
V V Zholos, and
N M Otroshchenko, and
M V Savchenko, and
I A Nekrasova, and
L A Ivanova, and
V I Krishtopa
April 1974,
Gigiena i sanitariia,
Iu N Talakin, and
L V Chernykh, and
V V Zholos, and
N M Otroshchenko, and
M V Savchenko, and
I A Nekrasova, and
L A Ivanova, and
V I Krishtopa
January 1970,
Acta poloniae pharmaceutica,
